IL6 and Other metabolic disease: Biomarker-based investigations, including IL-6, C-reactive protein, TNF-α, and adipokines, may provide mechanistic insights into the interplay between cutaneous inflammation and systemic metabolic dysfunction, as well as identify shared inflammatory pathways between dermatologic and metabolic diseases.